Prostate cancer: the first penile prosthesis 50 years ago. But few get it after a tumor from the NHS
Half a century ago a team of surgeons in Texas had the intuition to create the first prosthesis that replaces...
Half a century ago a team of surgeons in Texas had the intuition to create the first prosthesis that replaces...
Metastatic prostate cancer resistant to testosterone-suppressing drugs, associated with the development of the tumor, is the most difficult to treat...
In recent decades, cases of prostate cancer have increased. The reason? Mainly because the tools capable of leading to an...
When prostate cancer spreads or becomes metastatic, but is newly diagnosed where the cancer has already spread, the disease is...
Artificial Intelligence to identify predictive biomarkers and increasingly personalize prostate cancer treatments. It is a not at all distant scenario...
Let's go back to talking about prostate cancer, the most common among the male population aged 50 and over, and,...
There is news for patients with metastatic hormone sensitive prostate cancer (mHSPC). For the treatment of this tumour, (CHMP) of...
Expanding the use of a targeted oral drug for metastatic castration-resistant prostate cancer (mCRPC) in European Union countries. The European...
In European countries, the treatment of advanced prostate cancer becomes precision and "nuclear". The European Commission has in fact given...
It is the most frequent side effect and the greatest fear of all those men who have to undergo surgery...
Every year, in Italy, about 7 thousand men are diagnosed with a severe form of prostate cancer, metastatic cancer, ie...